Pfizer PGN 330 (Lyrica CR 330 mg)
Generic Name: pregabalin
Pill with imprint Pfizer PGN 330 is Pink, Elliptical / Oval and has been identified as Lyrica CR 330 mg. It is supplied by Pfizer Inc..
Lyrica CR is used in the treatment of neuropathic pain; diabetic peripheral neuropathy; postherpetic neuralgia and belongs to the drug class gamma-aminobutyric acid analogs. Risk cannot be ruled out during pregnancy. Lyrica CR 330 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
Images for Pfizer PGN 330
- Generic Name:
- Pfizer PGN 330
- 330 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Gamma-aminobutyric acid analogs
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 5 - Some potential for abuse
- Labeler / Supplier:
- Pfizer Inc.
- National Drug Code (NDC):
More about Lyrica CR (pregabalin)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- 0 Reviews – Add your own review/rating
- Drug class: gamma-aminobutyric acid analogs
Other brands: Lyrica
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.